Prognosis and Survival Estimates in Palliative Therapy

Heinrich-Heine University, Duesseldorf612 enrolled

Overview

The accuracy of clinical survival estimates is tested in comparison to objective prognostic scores.

* At presentation a clinical survival estimate is obtained in each patient. * Survival is also estimated using published prognostic scores in palliative care. * Prognostic scores based on blood samples, general symptoms, complaints, and performance status are calculated and validated, respectively * Each patient completes questionnaires on psychological distress * Survival estimates are limited to 6 months. * Each patient is followed for at least 6 months.

Study Type

OBSERVATIONAL

Enrollment

612

Conditions

Cancer

Interventions

no specific interventionsOTHER

There are no specific interventions in this observational study

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * oncologic disease confirmed * incurable locally advanced or metastatic disease * palliative treatment intended * age \> 18 * able to understand the study protocol * able to complete the forms with assistance if necessary Exclusion Criteria: * therapy with curative intent * regular clinical follow-up visit without disease progression * ongoing therapy

Locations (3)

University Hospital Duesseldorf, Radiation Oncology Dept.

Düsseldorf, North Rhine-Westphalia, Germany

Sana Kliniken Duesseldorf Benrath

Düsseldorf, North Rhine-Westphalia, Germany

Sana Kliniken Duesseldorf Gerresheim, MVZ Onkologie

Düsseldorf, North Rhine-Westphalia, Germany

Outcomes

Primary Outcomes

Survival

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.